Dialysis industry news

Stories from the dialysis comunity across the globe.



Research and Markets: Poland Nephrology and Urology Devices Investment ... - Business Wire (press release) PDF Print

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/3tb3br/poland_nephrology) has announced the addition of Global Markets Direct's new report "Poland Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2018" to their offering.

“Poland Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2018”

Poland Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2018, a new report by Global Markets Direct, provides key market data on the Poland Nephrology and Urology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within three market categories - Incontinence Devices, Lithotripters and Renal Dialysis Equipment. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.

Scope

- Market size and company share data for Nephrology and Urology Devices market categories - Incontinence Devices, Lithotripters and Renal Dialysis Equipment.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within three market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the three market categories.

- Global corporate-level profiles of key companies operating within the Poland Nephrology and Urology Devicesmarket.

- Key players covered include Fresenius Medical Care AG & Co. KGaA, Gambro AB, Baxter International Inc., Svenska Cellulosa Aktiebolaget SCA, HARTMANN GROUP, B. Braun Melsungen AG and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the Poland Nephrology and Urology Devices competitive landscape.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Companies Mentioned

- Fresenius Medical Care AG & Co. KGaA

- Gambro AB

- Baxter International Inc.

- Svenska Cellulosa Aktiebolaget SCA

- HARTMANN GROUP

- B. Braun Melsungen AG

- ONTEX International N.V.

- First Quality Enterprises, Inc.

- Coloplast A

S

- Astra Tech Inc.

- Kimberly-Clark Corporation

- NIPRO CORPORATION

- Covidien plc

- Dornier MedTech GmbH

- STORZ MEDICAL AG

- Abena A/S

- Medline Industries, Inc.

- Siemens Healthcare

For more information visit http://www.researchandmarkets.com/research/3tb3br/poland_nephrology

Source: Global Markets Direct

...

 
Research and Markets: Finland Nephrology and Urology Devices ... - Business Wire (press release) PDF Print

DUBLIN--(BUSINESS WIRE)--Dublin - Research and Markets (http://www.researchandmarkets.com/research/6pl44c/finland_nephrology) has announced the addition of Global Markets Direct's new report "Finland Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2018" to their offering.

“Finland Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2018”

Finland Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2018, a new report by Global Markets Direct, provides key market data on the Finland Nephrology and Urology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within three market categories - Incontinence Devices, Lithotripters and Renal Dialysis Equipment. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.

Scope

- Market size and company share data for Nephrology and Urology Devices market categories - Incontinence Devices, Lithotripters and Renal Dialysis Equipment.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within three market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the three market categories.

- Global corporate-level profiles of key companies operating within the Finland Nephrology and Urology Devicesmarket.

- Key players covered include Fresenius Medical Care AG & Co. KGaA, Svenska Cellulosa Aktiebolaget SCA, Gambro AB, Baxter International Inc., ONTEX International N.V., Coloplast A/S and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the Finland Nephrology and Urology Devices competitive landscape.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

For more information visit http://www.researchandmarkets.com/research/6pl44c/finland_nephrology

Source: Global Markets Direct

...

 
Research and Markets: Norway Nephrology and Urology Devices Investment ... - Business Wire (press release) PDF Print

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/d682qx/norway_nephrology) has announced the addition of Global Markets Direct's new report "Norway Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2018" to their offering.

“Norway Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2018”

Norway Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2018, a new report by Global Markets Direct, provides key market data on the Norway Nephrology and Urology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within three market categories - Incontinence Devices, Lithotripters and Renal Dialysis Equipment. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.

Scope

- Market size and company share data for Nephrology and Urology Devices market categories - Incontinence Devices, Lithotripters and Renal Dialysis Equipment.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within three market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the three market categories.

- Global corporate-level profiles of key companies operating within the Norway Nephrology and Urology Devices market.

- Key players covered include Svenska Cellulosa Aktiebolaget SCA, Fresenius Medical Care AG & Co. KGaA, HARTMANN GROUP, ONTEX International N.V., Baxter International Inc., Astra Tech Inc. and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the Norway Nephrology and Urology Devices competitive landscape.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

For more information visit http://www.researchandmarkets.com/research/d682qx/norway_nephrology

Source: Global Markets Direct

...

 
Research and Markets: Norway Nephrology and Urology Devices ... - Business Wire (press release) PDF Print

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/d682qx/norway_nephrology) has announced the addition of Global Markets Direct's new report "Norway Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2018" to their offering.

“Norway Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2018”

Norway Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2018, a new report by Global Markets Direct, provides key market data on the Norway Nephrology and Urology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within three market categories - Incontinence Devices, Lithotripters and Renal Dialysis Equipment. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.

Scope

- Market size and company share data for Nephrology and Urology Devices market categories - Incontinence Devices, Lithotripters and Renal Dialysis Equipment.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within three market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the three market categories.

- Global corporate-level profiles of key companies operating within the Norway Nephrology and Urology Devices market.

- Key players covered include Svenska Cellulosa Aktiebolaget SCA, Fresenius Medical Care AG & Co. KGaA, HARTMANN GROUP, ONTEX International N.V., Baxter International Inc., Astra Tech Inc. and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the Norway Nephrology and Urology Devices competitive landscape.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

For more information visit http://www.researchandmarkets.com/research/d682qx/norway_nephrology

Source: Global Markets Direct

...

 
Louisville's Kosair Children's Hospital ranked among nation's best [Fitness ... - Louisville.com PDF Print
Print Louisville's Kosair Children's Hospital

Kosair Children's Hospital in Louisville, Ky., the pediatric arm of Norton Healthcare, has been named as one of the nation’s top pediatric facilities by US News & World Report magazine today.  Admitting more than 200 children a day, Kosair Nursing was singled out for its nursing excellence, because of its status as a Nurse Magnet facility. Special recognition was given for its patient and family services, which include computer work stations, a family resource center, and sleep areas for parents and siblings.

US_NEWS_COVER__72.jpg The 2012-13 Best Children's Hospitals features 80 different hospitals that ranked among the top 50 in at least one of 10 specialties: cancer, cardiology and heart surgery, diabetes and endocrinology, gastroenterology, neonatology, nephrology, neurology and neurosurgery, orthopedics, pulmonology, and urology.  Kosair Children’s was specifically honored for being:  #16 in Pediatric Cancer, #38 in Pediatric Cardiology & Heart Surgery, #49 in Pediatric Nephrology, #29 in Pediatric Neurology & Neurosurgery, #24 in Pediatric Orthopedics, #24 in Pediatric Pulmonology, and #31 in Pediatric Urology. 

The rankings rely on an extensive data survey sent to a carefully selected set of hospitals, and a reputational survey sent to pediatric specialists. For the specialist survey, 150 physicians in each specialty were asked to name up to five hospitals they consider best for children with serious or difficult problems in their field, without regard to cost or geography. The last three years of responses were totaled.

kosair62.jpg Most of the 178 centers that were asked to complete the 95-page data survey are freestanding children's hospitals or large, multispecialty pediatric departments of major medical centers, run with their own staffs, ORs, and other facilities as if they were a hospital within a hospital. Other children's facilities were surveyed because they were previously ranked or were recommended by trusted sources. This year 100 hospitals completed the survey.

The magazine also ranks Norton Healthcare as the Number 1 hospital in the Louisville Metro area; with 12 “high-performing” specialties.  Kosair Children’s is ranked as the Number 1 pediatric hospital in the area; with 7 “nationally ranked” specialties.

kosair63.jpg FULL DISCLOSURE:  I was a polio patient at Kosair for 6 months in 1951, when the hospital was located at its old facility onEastern Parkway.  The nurses and physical therapists there taught me how to walk all over again.  My family did not have health insurance back in those days, and were never presented with a bill by those wonderful folks.  Years later, when my infant son experienced a severe neonatal infection, he was treated at the new Kosair Children’s Hospital for almost a week.  They saved his life.

Accordingly, readers should expect a certain degree of bias from this writer, in any discussion involvingKosair Hospital.

...

 
<< Start < Prev 581 582 583 584 585 586 587 588 589 590 Next > End >>

Page 588 of 4210
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.